Novel cell-free and concentrated ascites reinfusion therapy (KM-CART) for refractory ascites associated with cancerous peritonitis: its effect and future perspectives

被引：0
|
作者：
Keisuke Matsusaki
Keiichiro Ohta
Akitaka Yoshizawa
Yasuaki Gyoda
机构：
[1] Hofu Institute of Gastroenterology,Department of Surgery
[2] Gastroenterology Center,Department of Palliative Medicine
[3] International University of Health and Welfare Mita Hospital,undefined
[4] Kanamecho Hospital,undefined
来源：
International Journal of Clinical Oncology | 2011年 / 16卷
关键词：
Cancerous ascites; Reinfusion therapy; KM-CART;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：395 / 400
页数：5
相关论文
共 50 条
  • [1] Novel cell-free and concentrated ascites reinfusion therapy (KM-CART) for refractory ascites associated with cancerous peritonitis: its effect and future perspectives
    Matsusaki, Keisuke
    Ohta, Keiichiro
    Yoshizawa, Akitaka
    Gyoda, Yasuaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2011, 16 (04) : 395 - 400
  • [2] Treatment for refractory cancerous ascites: An invention to the novel cell-free and concentrated ascites reinfusion therapy (bedside KM-CART) -
    Doi, Akira
    Matsusaki, Keisuke
    Kayahara, Takahisa
    Matsueda, Kazuhiro
    Mizuno, Motowo
    Yamamoto, Hiroshi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 72 - 73
  • [3] Novel cell-free and concentrated ascites reinfusion therapy (KM-CART) for refractory ascites in candidates for liver transplantation
    Ohira, M.
    Sato, K.
    Imaoka, Y.
    Tanimine, N.
    Morimoto, H.
    Tahara, H.
    Ide, K.
    Kobayashi, T.
    Tanaka, Y.
    Ohdan, H.
    TRANSPLANTATION, 2021, 105 (08) : 91 - 91
  • [4] APPLICATION OF KM-CART (ADVANCED CELL-FREE AND CONCENTRATED ASCITES REINFUSION THERAPY) TREATMENT TO PATIENTS WITH CANCEROUS ASCITES
    Matsusaki, K.
    Ohta, K.
    Yoshizawa, A.
    Goto, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 463 - 464
  • [5] Palliative benefit of novel cell-free and concentrated ascites reinfusion therapy (CART) for refractory ascites associated with cancerous peritonitis.
    Matsusaki, Keisuke
    Yoshizawa, Akitaka
    Ohta, Kelichiro
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [6] SAFETY AND EFFICACY OF NOVEL CELL-FREE AND CONCENTRATED ASCITES REINFUSION THERAPY (KM-CART) FOR REFRACTORY ASCITES IN LIVER TRANSPLANT CANDIDATES
    Sato, Koki
    Ohira, Masahiro
    Imaoka, Yuki
    Hashimoto, Shinji
    Tahara, Hiroyuki
    Ide, Kentarao
    Kobayashi, Tsuyoshi
    Tanaka, Yuka
    Hideki, Ohdan
    TRANSPLANT INTERNATIONAL, 2019, 32 : 163 - 163
  • [7] Feasibility, efficacy, and safety of cell-free and concentrated ascites reinfusion therapy (KM-CART) for malignant ascites
    Matsusaki, Keisuke
    Orihashi, Kazumasa
    ARTIFICIAL ORGANS, 2020, 44 (10) : 1090 - 1097
  • [8] A study of cell-free and concentrated ascites reinfusion therapy (CART) for intractable ascites associated with cancerous ascites.
    Ueda, Yuki
    Katayama, Kanji
    Fujimoto, Daisuke
    Murakami, Makoto
    Hirono, Yasuo
    Goi, Takanori
    Yamaguchi, Akio
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [9] Clinical usefulness of concentrated ascites reinfusion therapy (CART) for gynecological cancer patients with refractory massive ascites due to cancerous peritonitis
    Togami, S.
    Hori, S.
    Kamio, M.
    Matsuo, T.
    Yoshinaga, M.
    Douchi, T.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2014, 35 (03) : 301 - 303
  • [10] CART: Cell-free and Concentrated Ascites Reinfusion Therapy against malignancy-related ascites
    Ito, Tetsuya
    Hanafusa, Norio
    TRANSFUSION AND APHERESIS SCIENCE, 2017, 56 (05) : 703 - 707
12345